Presentations from 6th Annual International Bladder Cancer Update
The Contribution of SWOG to Bladder Cancer Clinical Trials
Seth P. Lerner, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.
Alternative Payment Models: Value Care Bundling
C.J. Stimson, MD, JD, moderated this panel during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.
Panel Discussion: What Does the Future Hold?
Sam S. Chang, MD, MBA, moderated this panel during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.
Controversies in NMIBC: Guidelines and Beyond
Sam S. Chang, MD, MBA, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Use of Biomarkers in NMIBC: What’s New and What Should We Use?
Peter C. Black, MD, moderated this panel during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Risk Stratification: Moving from the Old to the New
Joshua J. Meeks, MD, PhD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Prioritizing the Optimal Therapy for T1 Bladder Cancer: Using the Old and the New To Determine What to Do
Seth P. Lerner, MD, moderated this panel during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Pathology of Urothelial Cancers
Donna E. Hansel, MD, PhD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
NMIBC Trials for BCG Naive Patients: What is Exciting
Joshua J. Meeks, MD, PhD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Enhanced Techniques of NMIBC Detection
Mark D. Tyson, II, MD, MPH, moderated this panel during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Panel Discussion: New Therapies for BCG Unresponsive NMIBC: Where Do We Stand?
Sam S. Chang, MD, MBA, moderated this panel during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Challenging Case Presentations
Mark D. Tyson, II, MD, MPH, moderated this case presentations during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Immune Checkpoint Inhibitors
Daniel P. Petrylak, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Immune Checkpoint Inhibitors: Combination Therapy
Jean H. Hoffman-Censits, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Immune Checkpoint Inhibitors: Managing Immune-related Side Effects
Guru P. Sonpavde, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Earlier Use of These Treatments Moving Into Adjuvant and NMIBC: What Do We Do About Patients for Reinduction of Immune Treatment?
Guru P. Sonpavde, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 19, 2022, in Scottsdale, Arizona.
Panel Discussion: Future Challenges to the Use of Immunotherapy: What’s the Right Timing and Sequencing?
Daniel P. Petrylak, MD, moderated this panel during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.
FGFR Kinase Inhibitors and Other Novel Targets in the Treatment of Metastatic Urothelial Cancer
Parminder Singh, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
The Use of Antibody-drug Conjugates in Treating Advanced Urothelial Cancer
Daniel P. Petrylak, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Targeted Therapy Combined with Immune Checkpoint Therapy: Is This the Wave of the Future?
Jean H. Hoffman-Censits, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Biomarker Integration for Advanced Urothelial Carcinoma
Donna E. Hansel, MD, PhD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Session V: Advanced Urothelial Cancer Part 2: Latest Research and Clinical Trials: Panel Discussion/Questions and Answers
Daniel P. Petrylak, MD, moderated this panel during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Biomarker Integration of Advanced Urothelial Carcinoma
Donna E. Hansel, MD, PhD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Methods and Guidelines to Stage and Grade (Low vs. High) UTUC and How Should We Treat
Seth P. Lerner, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
High Risk and Advanced Upper Tract Urothelial Carcinoma: Still a Role for Surgery?
Jennifer A. Linehan, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Session VI: Management of UTUC: Panel Discussion/Questions and Answers
Jennifer A. Linehan, MD, moderated this panel during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Neoadjuvant or Adjuvant Therapy?
Parminder Singh, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
What Should I Do About Micropapillae? Do I Treat it Differently Than Standard?
Donna E. Hansel, MD, PhD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Bladder Sparing Regimens for Muscle Invasive Disease: Should We Be Doing this More?
Peter C. Black, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.
Utilizing Molecular Characterization of Invasive Bladder Cancer: What It Means Now and In the Future
Jennifer A. Linehan, MD, presented this lecture during the 6th Annual International Bladder Cancer Update on November 20, 2022, in Scottsdale, Arizona.